Organization · Venture Capital
Cléry
Cléry is an impact investment firm based in Paris, France, founded by David Guinard and Robin Ucelli in late 2022. The firm focuses on sectors addressing societal and environmental challenges, emphasizing ethical and sustainable practices.
Overview
What Cléry does
What Cléry is
Cléry is an impact investment firm based in Paris, France, founded by David Guinard and Robin Ucelli in late 2022. The firm focuses on sectors addressing societal and environmental challenges, emphasizing ethical and sustainable practices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- March 28, 2026
Official channels
Find Cléry elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cléry as a funder
Investment thesis
Cléry focuses on long-term and impact investments across renewable energy and social innovation sectors, aiming to create positive societal and environmental changes while achieving healthy financial returns.
Focus narrative
Cléry invests in sectors that tackle pressing societal and environmental issues. Their focus areas include energy transition and climate change adaptation, preventive health and medical innovation, real estate and hospitality, decarbonization of mobility, and space technology. The firm emphasizes ethical and impactful investment practices.
Value beyond capital
Cléry adds value to its portfolio companies through strategic guidance, leveraging the founders' extensive experience in renewable energy and impact investing. The firm aims to support companies in achieving their sustainability goals while enhancing operational efficiency and market reach.
Focus and fit
- Stages
- Friends and Family · Angel · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Regions
- Europe · Fr · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 14
- Recorded notable exits
- Photosol
Portfolio context
Cléry's portfolio features innovative companies such as AdEchoTech, which develops remote ultrasound solutions; Alatyr, creating robotic micro-laboratories for biotherapy; and Carbo Culture, focused on biochar production for carbon sequestration. Other notable companies include Clarity Health Technologies, Cold Pad, Hepta Medical, inHeart, NeoFarm, Notpla Limited, Onafis by My Bacchus, One.five, Primaa, Separative, Tafalgie Therapeutics, and Zeway.
Common questions
What to know about Cléry
Upseed classifies Cléry under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.